An innovation plan to beat Covid-19
MIT economist Pierre Azoulay outlines a roadmap for scientific success against the virus.
MIT economist Pierre Azoulay outlines a roadmap for scientific success against the virus.
Decisions on when to return to campus await more information but may involve a phased process and continued precautions.
MIT professor’s research group leverages its capability for testing filtration efficiency to assess certain respirators for MEMA, others.
MIT professor and intensivist/trauma surgeon explains the new challenges that Covid-19 brings to treating patients in acute respiratory distress.
Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
Inaugural AI Powered Drug Discovery and Manufacturing Conference drew pharmaceutical companies, government regulators, and pioneering drug researchers.
Study finds specific cells in the lungs, nasal passages, and intestines that are more susceptible to infection.
MIT professor and writer examines the large-scale reaction to our new public health crisis.
Team designs antibody-like receptor proteins that can bind to cytokines, as possible strategy for treating coronavirus and other infections.
A machine learning algorithm combines data on the disease's spread with a neural network, to help predict when infections will slow down in each country.
“Data scientists and visualization designers need to take their civic role very seriously in a pandemic,” says the MIT assistant professor.
Materials scientist explores why some household cleaners could harm the protective coating on a smartphone screen.
MIT Solve 2020 Challenge seeks tech-based solutions to health security challenges, including Covid-19 and future pandemics.
The Institute is supporting Cambridge’s nonprofits, small businesses, and residents.
Critical research continues, students and staff are receiving support, and contingency planning proceeds for eventual phased reopening.